Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?
Expert Review of Precision Medicine and Drug Development - United Kingdom
doi 10.1080/23808993.2017.1289066
Full Text
Open PDFAbstract
Available in full text
Date
January 2, 2017
Authors
Publisher
Informa UK Limited